Yes, thank you, Mr. Speaker. Mr. Speaker, yes, the department is interested in targeting the most high risk population, which is that 65 to 70-year-old group. Also, people who are receiving active cancer treatment who are immune compromised. And the NHIB program offers an exception to the 65 to 70 age group. People can apply for coverage if they feel they can make a case for that with NHIB.

Having said all of that, I think that the Member's suggestion is a good one, that we provide a more targeted campaign to encourage uptake on the vaccine for the 65 to 70 group and for those who have benefits, as I say, who might be able to get it sooner, to go ahead and do that rather than deal with the pain and potential long-term consequences of shingles. Thank you.